Literature DB >> 23931933

Reproductive factors and clinical features of Parkinson's disease.

Emanuele Cereda1, Michela Barichella, Erica Cassani, Riccardo Caccialanza, Gianni Pezzoli.   

Abstract

BACKGROUND: Literature suggests that sex steroid hormones may modify the risk for Parkinson's disease (PD). We investigated the potential effect of reproductive factors on the clinical features of idiopathic PD (IPD) patients.
METHODS: All IPD female patients admitted to and evaluated at our Institute over a 12-month period were included in the present cross-sectional study. We investigated the effect of the following parameters by multivariate linear regression analysis: age at menarche, age at menopause, length of fertile life, duration of exposure to endogenous estrogens and cumulative length of pregnancies, use of contraceptives and hormonal replacement therapy.
RESULTS: In total, 579 patients were evaluated and 497 reported menopause before PD onset. In this population, age at PD onset was positively associated with age at menarche and at menopause, length of fertile life and duration of estrogen exposure. Moreover, UPDRS motor score was inversely associated with age at menopause, length of fertile life and duration of estrogen exposure. Increasing age at menarche was also associated with predominant resting tremor at PD onset. In models refitted on patients with early PD (disease duration <5 years; N = 226) all the associations found were confirmed. The relationship between surrogates of estrogen exposure and UPDRS motor score actually became more significant.
CONCLUSIONS: Our observations support the concept that hormonal exposure of the nigro-striatal network during life may influence its susceptibility to degenerative stimuli in later life, but the association does not seem to be unique? unidirectional. In particular, increased severity of PD signs correlates with shorter duration of estrogen exposure. The underlying mechanisms need to be clarified.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clinical features; Estrogens; Parkinson's disease; Reproductive factors

Mesh:

Year:  2013        PMID: 23931933     DOI: 10.1016/j.parkreldis.2013.07.020

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  16 in total

Review 1.  Estrogenic Endocrine Disrupting Chemicals Influencing NRF1 Regulated Gene Networks in the Development of Complex Human Brain Diseases.

Authors:  Mark Preciados; Changwon Yoo; Deodutta Roy
Journal:  Int J Mol Sci       Date:  2016-12-13       Impact factor: 5.923

2.  Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study.

Authors:  Hee Kyung Park; Sindana Ilango; Christina M Charriez; Harvey Checkoway; David Riley; David G Standaert; Yvette Bordelon; David R Shprecher; Stephen G Reich; Deborah Hall; Benzi Kluger; Connie Marras; Joseph Jankovic; Richard Dubinsky; Irene Litvan
Journal:  Mov Disord       Date:  2018-02-20       Impact factor: 10.338

Review 3.  The relevance of gender in Parkinson's disease: a review.

Authors:  Marina Picillo; Alessandra Nicoletti; Vincenza Fetoni; Barbara Garavaglia; Paolo Barone; Maria Teresa Pellecchia
Journal:  J Neurol       Date:  2017-01-04       Impact factor: 4.849

Review 4.  Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease.

Authors:  Raja Mehanna; Katarzyna Smilowska; Jori Fleisher; Bart Post; Taku Hatano; Maria Elisa Pimentel Piemonte; Kishore Raj Kumar; Victor McConvey; Baorong Zhang; Eng-King Tan; Rodolfo Savica
Journal:  Mov Disord Clin Pract       Date:  2022-09-10

5.  Increase of Reproductive Life Span Delays Age of Onset of Parkinson's Disease.

Authors:  Dominik Frentzel; Grigorij Judanin; Olga Borozdina; Jochen Klucken; Jürgen Winkler; Johannes C M Schlachetzki
Journal:  Front Neurol       Date:  2017-08-21       Impact factor: 4.003

6.  Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease.

Authors:  Francesca Siani; Rosaria Greco; Giovanna Levandis; Cristina Ghezzi; Francesca Daviddi; Chiara Demartini; Elisabetta Vegeto; Marie-Thérèse Fuzzati-Armentero; Fabio Blandini
Journal:  Front Neurosci       Date:  2017-05-31       Impact factor: 4.677

7.  Should Exercise Be Prescribed Differently Between Women and Men? An Emphasis on Women Diagnosed With Parkinson's Disease.

Authors:  Brandon R Rigby; Ronald W Davis
Journal:  Front Physiol       Date:  2018-08-02       Impact factor: 4.566

8.  Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson's disease.

Authors:  Yang Hyun Lee; Jungho Cha; Seok Jong Chung; Han Soo Yoo; Young H Sohn; Byoung Seok Ye; Phil Hyu Lee
Journal:  Sci Rep       Date:  2019-07-19       Impact factor: 4.379

Review 9.  Is there a Neurobiological Rationale for the Utility of the Iowa Gambling Task in Parkinson's Disease?

Authors:  Michael F Salvatore; Isabel Soto; Helene Alphonso; Rebecca Cunningham; Rachael James; Vicki A Nejtek
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

10.  Gender Differences in Age-Related Striatal Dopamine Depletion in Parkinson's Disease.

Authors:  Jae Jung Lee; Jee Hyun Ham; Phil Hyu Lee; Young H Sohn
Journal:  J Mov Disord       Date:  2015-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.